Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gotcha...Jan 8th can't get here soon enough...lol
Wow! Anyone else here besides me think that the company just dumped those 750,000 shares at .0044?
sanMillon...at the rate this company gives out news, it would take about a decade for us to hear half of that...lol. I really hope we get some news here on the 8th!
Happy New Year!! Looking forward to hearing some updates from the company and hopefully hearing about it being sold to a Big Pharma company! GLTA
Unfortunately all we can do is speculate on the Patent hearings because the company won't give us any information on it good or bad. This was from February of this year so I would imagine they would have to have information on this hearing. Just another thing on the long list of items that the company hasn't updated it shareholders on. I really don't know what is more frustrating to think of...either the company has a ton of info they are holding onto and aren't releasing or there is no information for them to give. Please sell this company already!...lol. GLTA
Wishing everybody on the board a Merry Christmas! and if ya don't celebrate Christmas then Happy Holidays!
James...try calling the transfer agent. They should give you an updated outstanding share count as of today.
I have no idea why they post out of date info or info that has nothing to do with Intellect.
mkaiz..that was an old article from before the phase 3 trials came out for both Bapi and Solanezumab. They both failed to reach their endpoints. However, I believe Bapi might still have a chance at being studied for treatment in the earliest stages of Alzheimer's. Solanezumab I believe received 100 million dollar grant and is back in phase 3 studies already. I believe the results for those phase 3 trials are due in 2018
Finally a paint job on the upside..lol. News of a buyout this monday would really make this a great Christmas! GLTA
Deals, I can assure you I dont want this stock going lower and I am not trying to get others to sell. As I have stated before, Im here bust or boom. There is just nothing positive to post about right now...no news from the company to go on.
Well they filled 400 shares at .0042...lol. This is getting really bad here. This stock would have to more than double just to get to a penny.
Wonder if they will fill that order for 100,000 shares at .0042 once the rest of the .0049 block is gone
Am I seeing this correctly? Did we open at .0041 today?
I saw that right in the beginning of the day. Who the hell trades 30 shares of a stock that trades in the .004 to .005 range?
Hope we get some news this week on a buyout.
Im gonna say that there has probably been at least 30 million more shares added to the float since the Nov 19.
It seems like there is an endless supply of stock at .005. Im almost 100% sure this is the company dumping more shares.
I think I was wrong about Bapi and phase 2 trials. Just went to clinical trials.gov after reading the link buckii posted, and It looks like every trial is either terminated or completed. Ponzeumab is still recruiting for their phase 2 trial however.
Intellect has nothing to do with solenzumab.
We are in total agreement about the CONJUMAB platform Deals. I believe that is the major attraction for a buyout.
If you are talking about solanezumab when you say Soley then you would be wrong about that. Intellect has no involvement with solanezumab. Bapi and Ponzeumab are both being retested in phase 2 on patients in the earliest stages of the disease I believe, so both of those drugs are years and years away from gaining any FDA approval, if they in fact gained approval. OX1 is recruiting for phase 1b and since Shire has bought Viopharma Im not sure what pace they intend to bring OX1 along. So OX1 is still quite a few years away from gaining any FDA approval (If it does gain approval). I think a buyout is more likely soon, I can't see Intellect still being around years from now when and if any of their science gains FDA approval. GLTY
Thanks for the response cable. My feeling is there will be a buyout here (hopefully). I believe Dr. Chain came back as a consultant (instead of taking Intellect to court for the wages and benefits he claimed to have lost) so he could receive monies once the sale was complete. It seems most of us are pretty much on the same page here, we just differ for how much the company will be sold for. GLTY
cablejohn...if I may pick your brain for a minute. Do you think there will be a buyout here, or are you leaning more towards thinking that Intellect is going to receive a favorable decision and award from Pfzier and then in turn use that money to get a new CEO, CFO...etc. Then after doing that, partnering up with another large pharma to take their science into human trials?
I am definitely here until the 8th shaka. Im here boom or bust, just putting my thoughts out there as we go. GLTY
I can't get over just how many shares are out there for .005. Im thinking this is the company selling shares.
Mkaiz, Intellect won't last long enough to have a lead drug candidate go into late phase 3 trials getting ready for fda approval. In fact I don't believe Intellect will make it through 2014. They need a buyout now. The Viopharma deal for OX1 (now Shire owns it, so its anybodys guess what they plan to do with it) only gives Intellect royalties if the drug were approved. The company is only operating now by dumping shares into the market to pay for its day to day operations. There will not be a partnership because there is no one to partner up with at Intellect. No CEO, CFO, or Scientific Officer. I think their CONJUMAB platform is there best bet to be bought out. It is ready to go into phase one trials for AMD and I think a large Pharma would be willing to risk a few bucks to buy it.
You hit the nail on the head with that post deals.
I see your point derrickcan
So Im taking that you're a no on that question derrickcan
Im not much of a chartist so I'll take your word for it. I have to ask the board a question...am I the only one who thinks that Pfzier will appeal the Judges decision if it is indeed favorable for Intellect?
Whoops...spoke too soon lol.
Looks like there are a lot of shares out there for .005. Im wondering if this might be the bottom for the stock...
Finally somebody on the same page as me here..lol. I think the biggest thing Intellect has going for it is their CONJUMAB platform which they are planning to use to treat AMD. It is ready to go into phase 1 trials and I think its worth a lot. The only thing is Intellect really doesnt have any leverage when it comes to negotiating a buy out so I feel they won't get the money they deserve. I am still holding out a little hope for .03 to .05, but every week that goes by my hope gets less and less.
The news I want to hear is that the company has been sold. I believe anything other than a complete sale of the company would be a disaster for Intellect shareholders. A Partnership I feel wont happen because there is no one at Intellect left to Partner up with, and a merger or sale of parts of the company would pretty much destroy anyones investment here. GLYA ....come on sale!!
Believe me NOPRESSURE, I understand that. Just asking Deals if he indeed ended up in NY and if all his questions to Chain and Maza were answered by email.
Deals, did you make it to NY or did you receive all the info you wanted by email?
Agree with you about the share count there James.
No problem mkaiz, I understand your frustration. GLTY
mkaiz, If the company gave me something to be positive about then I would post positive. I have my opinion with what is going on with the company and you have yours. You are entitled to voice your opinions and so am I. GLTY